Oasmia Pharmaceutical
Uppsala
About Oasmia Pharmaceutical
Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. The product development is based on in-house research within nanotechnology and company patents.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $37.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2019)
- Ticker: sto:OASM
- Website: oasmia.com
- Phone: +46 18 50 54 40
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/oasmia-pharmaceutical-179873 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.